by kmoffitt6 | June 10, 2014 1:15 am
So many biotechs, so little time. A biotech, IDIX, gained 229% today on news that Merck will be buying this company that is developing a hepatitis C drug. It always amazes me when I see this happen to a stock that I haven’t seen teased! Hindsight highlights the good, bad, and envious:-)
Source URL: https://www.stockgumshoe.com/2014/06/microblog-a-229-biotech/
Copyright ©2024 Stock Gumshoe unless otherwise noted.
Leave a Reply